Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity
- 1 April 2000
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (7) , 575-582
- https://doi.org/10.1038/sj.gt.3301128
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 39 references indexed in Scilit:
- Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responsesGene Therapy, 1998
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997
- IN VIVO DEPLETION OF CD8+ T CELLS RESULTS IN Th2 CYTOKINE PRODUCTION AND ALTERNATE MECHANISMS OF ALLOGRAFT REJECTIONTransplantation, 1995
- MULTIPLE VECTORS EFFECTIVELY ACHIEVE GENE TRANSFER IN A MURINE CARDIAC TRANSPLANTATION MODEL IMMUNOSUPPRESSION WITH TGF-β OR vIL-10Transplantation, 1995
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytesEuropean Journal of Immunology, 1994
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFIScience, 1990